Undetectable anti‐TNF drug levels in patients with long‐term remission predict successful drug withdrawal

E-ISSN： 1365-2036|42|3|356-364

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.3, 2015-08, pp. : 356-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: early post‐induction anti‐TNF drug monitoring can predict long‐term therapeutic outcomes in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 436-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNF Drug

Current Drug Safety, Vol. 1, Iss. 3, 2006-08 ,pp. : 259-264

Bentham Science Publishers

Access to resources Recommend Favorite

Drug therapy increases long-term survival in pulmonary hypertension patients

By Senior K.

The Lancet, Vol. 360, Iss. 334, 2002-08 ,pp. : 696-696

Elsevier

Access to resources Recommend Favorite

Long-term safety of drug-eluting stents in patients on warfarin treatment

By Annala Antti-Pekka Karjalainen Pasi P. Biancari Fausto Niemelä Matti Ylitalo Antti Vikman Saila Porela Pekka Airaksinen K. E. Juhani

Annals of Medicine, Vol. 44, Iss. 3, 2012-05 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

The long‐term effects of anti‐TNF‐α agents on patients with chronic viral hepatitis C and B infections

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 40-45

John Wiley & Sons Inc

Access to resources Recommend Favorite